Search company, investor...

Abacus Bioscience

abacusbioscience.com

Founded Year

2018

Stage

Seed VC | Alive

Total Raised

$4.52M

Last Raised

$4.4M | 4 mos ago

About Abacus Bioscience

Abacus Bioscience specializes in developing novel immunotherapeutic treatments for managing cancer and antiviral diseases using a CD180 backbone. It provides medical practitioners with a broad-based platform that can plug and play with various cancer or viral antigens. The company was founded in 2018 and is based in Seattle, Washington.

Headquarters Location

4545 Roosevelt Way Northeast Suite 400

Seattle, Washington, 98105,

United States

Missing: Abacus Bioscience's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Abacus Bioscience's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Abacus Bioscience Patents

Abacus Bioscience has filed 4 patents.

The 3 most popular patent topics include:

  • Animal viral diseases
  • Vaccination
  • Vaccines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/15/2018

7/19/2022

Clusters of differentiation, Monoclonal antibodies, Immunology, Immune system, Molecular biology

Grant

Application Date

11/15/2018

Grant Date

7/19/2022

Title

Related Topics

Clusters of differentiation, Monoclonal antibodies, Immunology, Immune system, Molecular biology

Status

Grant

Abacus Bioscience Frequently Asked Questions (FAQ)

  • When was Abacus Bioscience founded?

    Abacus Bioscience was founded in 2018.

  • Where is Abacus Bioscience's headquarters?

    Abacus Bioscience's headquarters is located at 4545 Roosevelt Way Northeast, Seattle.

  • What is Abacus Bioscience's latest funding round?

    Abacus Bioscience's latest funding round is Seed VC.

  • How much did Abacus Bioscience raise?

    Abacus Bioscience raised a total of $4.52M.

  • Who are the investors of Abacus Bioscience?

    Investors of Abacus Bioscience include WRF Capital, University of Washington and Washington Research Foundation.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.